The human immunoglobulin A Fc receptor FcαRI: A multifaceted regulator of mucosal immunity

Mucosal Immunology

Volumn 4, Issue 6, 2011, Pages 612-624

  Bakema, J E ^a   Van Egmond, M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A FC RECEPTOR; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; CANCER CHEMOTHERAPY; CELL FUNCTION; DRUG EFFECT; DRUG TARGETING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HELICOBACTER INFECTION; IMMUNOGLOBULIN A FC RECEPTOR GENE; IMMUNOGLOBULIN GENE; IMMUNOMODULATION; IMMUNOREGULATION; INFECTION; INFECTION PREVENTION; INFLAMMATORY DISEASE; INFLUENZA; LIGAND BINDING; MUCOSAL IMMUNITY; NEOPLASM; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SHIGELLOSIS; SIGNAL TRANSDUCTION;

EID: 80054954035     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2011.36     Document Type: Review

References (191)

1. Fagarasan S. & Honjo T. Intestinal IgA synthesis: regulation of front-line body defences. Nat. Rev. Immunol 3 63-72 ( 2003 (Pubitemid 37328700)
2. Pamer E. G. Immune responses to commensal and environmental microbes. Nat. Immunol. 8 1173-1178 ( 2007 (Pubitemid 350011753)
3. Macpherson A. J. et al. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 288 2222-2226 ( 2000 (Pubitemid 30429609)
4. Woof J. M. & Kerr M. A. The function of immunoglobulin A in immunity. J. Pathol. 208 270-282 ( 2006 (Pubitemid 43126119)
5. Johansen F. E. Braathen R. & Brandtzaeg P. The J chain is essential for polymeric Ig receptor-mediated epithelial transport of IgA. J. Immunol. 167 5185-5192 ( 2001 (Pubitemid 33009755)
6. Braathen R. Sorensen V. Brandtzaeg P. Sandlie I. & Johansen F. E. The carboxyl-terminal domains of IgA and IgM direct isotype-specifi c polymerization and interaction with the polymeric immunoglobulin receptor. J. Biol. Chem 277 42755-42762 ( 2002 (Pubitemid 35285648)
7. Lewis M. J. Pleass R. J. Batten M. R. Atkin J. D. & Woof J. M. Structural requirements for the interaction of human IgA with the human polymeric Ig receptor. J. Immunol. 175 6694-6701 ( 2005 (Pubitemid 41598913)
8. Mostov K. E. Transepithelial transport of immunoglobulins. Annu. Rev. Immunol. 12 63-84 ( 1994 (Pubitemid 24140409)
9. Shibuya A. et al. Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes. Nat. Immunol. 1 441-446 ( 2000
10. Stockert R. J. Kressner M. S. Collins J. C. Sternlieb I. & Morell A. G. IgA interaction with the asialoglycoprotein receptor. Proc. Natl Acad. Sci. USA 79 6229-6231 ( 1982 (Pubitemid 13219839)
11. Moura I. C. et al. Identifi cation of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J. Exp. Med. 194 417-425 ( 2001 (Pubitemid 32835038)
12. Lamkhioued B. et al. Human eosinophils express a receptor for secretory component. Role in secretory IgA-dependent activation. Eur. J. Immunol. 25 117-125 ( 1995
13. Mantis N. J. et al. Selective adherence of IgA to murine Peyer's patch M cells: evidence for a novel IgA receptor. J. Immunol. 169 1844-1851 ( 2002 (Pubitemid 34857646)
14. Reljic R. In search of the elusive mouse macrophage Fc-alpha receptor. Immunol. Lett. 107 80-81 ( 2006 (Pubitemid 44332542)
15. Woof J. M. & Kerr M. A. IgA function - variations on a theme. Immunology 113 175-177 ( 2004 (Pubitemid 39312444)
16. Maruoka T. Nagata T. & Kasahara M. Identifi cation of the rat IgA Fc receptor encoded in the leukocyte receptor complex. Immunogenetics 55 712-716 ( 2004
17. Morton H. C. et al. Cloning and characterization of an immunoglobulin A Fc receptor from cattle. Immunology 111 204-211 ( 2004 (Pubitemid 38177950)
18. Morton H. C. Pleass R. J. Storset A. K. Brandtzaeg P. & Woof J. M. Cloning and characterization of equine CD89 and identifi cation of the CD89 gene in chimpanzees and Rhesus macaques. Immunology 115 74-84 ( 2005 (Pubitemid 40593293)
19. Morton H. C. IgA Fc receptors in cattle and horses. Vet. Immunol. Immunopathol. 108 139-143 ( 2005 (Pubitemid 41317074)
20. Kazeeva T. N. & Shevelev A. B. IgA-specifi c proteins of pathogenic bacteria. Biochemistry (Mosc) 74 12-21 ( 2009
21. Kremer E. J. et al. The gene for the human IgA Fc receptor maps to 19q13.4. Hum. Genet. 89 107-108 ( 1992
22. Martin A. M. Kulski J. K. Witt C. Pontarotti P. & Christiansen F. T. Leukocyte Ig-like receptor complex (LRC) in mice and men. Trends Immunol. 23 81-88 ( 2002 (Pubitemid 34310149)
23. Daeron M. Fc receptor biology. Annu. Rev. Immunol. 15 203-234 ( 1997 (Pubitemid 27169280)
24. Nimmerjahn F. & Ravetch J. V. Fc gamma receptors: old friends and new family members. Immunity 24 19-28 ( 2006 (Pubitemid 43077197)
25. Monteiro R. C. & Van De Winkel J. G. IgA Fc receptors. Annu. Rev. Immunol. 21 177-204 ( 2003 (Pubitemid 37174530)
26. Ono M. Yuasa T. Ra C. & Takai T. Stimulatory function of paired immunoglobulin-like receptor-A in mast cell line by associating with subunits common to Fc receptors. J. Biol. Chem. 274 30288-30296 ( 1999
27. Maliszewski C. R. March C. J. Schoenborn M. A. Gimpel S. & Shen L. Expression cloning of a human Fc receptor for IgA. J. Exp. Med. 172 1665-1672 ( 1990
28. de Wit T. P. Morton H. C. Capel P. J. & van de Winkel J. G. Structure of the gene for the human myeloid IgA Fc receptor (CD89). J. Immunol. 155 1203-1209 ( 1995
29. Morton H. C. van Egmond M. & van de Winkel J. G. Structure and function of human IgA Fc receptors (Fc alpha R). Crit. Rev. Immunol. 16 423-440 ( 1996 (Pubitemid 26419111)
30. Toyabe S. Kuwano Y. Takeda K. Uchiyama M. & Abo T. IgA nephropathy-specifi c expression of the IgA Fc receptors (CD89) on blood phagocytic cells. Clin. Exp. Immunol. 110 226-232 ( 1997 (Pubitemid 27469595)
31. Shimokawa T. Tsuge T. Okumura K. & Ra C. Identifi cation and characterization of the promoter for the gene encoding the human myeloid IgA Fc receptor (Fc alphaRCD89). Immunogenetics 51 945-954 ( 2000
32. Shimokawa T. & Ra C. C/EBP alpha and Ets protein family members regulate the human myeloid IgA Fc receptor (Fc alpha RCD89) promoter. J. Immunol. 170 2564-2572 ( 2003 (Pubitemid 36245647)
33. Shimokawa T. & Ra C. C/EBPalpha functionally and physically interacts with GABP to activate the human myeloid IgA Fc receptor (Fc alphaRCD89) gene promoter. Blood 106 2534-2542 ( 2005 (Pubitemid 41510831)
34. Monteiro R. C. Kubagawa H. & Cooper M. D. Cellular distributionregulationand biochemical nature of an Fc alpha receptor in humans. J. Exp. Med. 171 597-613 ( 1990 (Pubitemid 20088968)
35. Monteiro R. C. Cooper M. D. & Kubagawa H. Molecular heterogeneity of Fc alpha receptors detected by receptor-specifi c monoclonal antibodies. J. Immunol. 148 1764-1770 ( 1992
36. Monteiro R. C. et al. Defi nition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals. J. Clin. Invest. 92 1681-1685 ( 1993 (Pubitemid 23304530)
37. Patry C. Sibille Y. Lehuen A. & Monteiro R. C. Identifi cation of Fc alpha receptor (CD89) isoforms generated by alternative splicing that are differentially expressed between blood monocytes and alveolar macrophages. J. Immunol. 156 4442-4448 ( 1996 (Pubitemid 26165846)
38. van Dijk T. B. et al. Cloning and characterization of Fc alpha Rba novel Fc alpha receptor (CD89) isoform expressed in eosinophils and neutrophils. Blood 88 4229-4238 ( 1996 (Pubitemid 26399169)
39. van Zandbergen G. et al. Crosslinking of the human Fc receptor for IgA (Fc alphaRI/CD89) triggers FcR gamma-chain-dependent shedding of soluble CD89. J. Immunol. 163 5806-5812 ( 1999
40. Yin N. Peng M. Xing Y. & Zhang W. Intracellular pools of Fc alphaR (CD89) in human neutrophils are localized in tertiary granules and secretory vesiclesand two Fc alphaR isoforms are found in tertiary granules. J. Leukoc. Biol. 82 551-558 ( 2007 (Pubitemid 47367145)
41. Pleass R. J. Andrews P. D. Kerr M. A. & Woof J. M. Alternative splicing of the human IgA Fc receptor CD89 in neutrophils and eosinophils. Biochem. J. 318 (Pt 3) 771-777 ( 1996
42. Togo S. Shimokawa T. Fukuchi Y. & Ra C. Alternative splicing of myeloid IgA Fc receptor (Fc alpha RCD89) transcripts in infl amatory responses. FEBS Lett. 535 205-209 ( 2003 (Pubitemid 36126382)
43. Reterink T. J. Verweij C. L. van Es L. A. & Daha M. R. Alternative splicing of IgA Fc receptor (CD89) transcripts. Gene 175 279-280 ( 1996 (Pubitemid 26363032)
44. Pleass R. J. Dunlop J. I. & Woof J. M. Multiple transcripts of human IgA Fc receptor CD89 in neutrophilseosinophils and the monocyte-like cell line THP-1. Biochem. Soc. Trans. 25 327S ( 1997 (Pubitemid 27261087)
45. van Vuuren A. J. van Egmond M. Coenen M. J. Morton H. C. & van de Winkel J. G. Characterization of the human myeloid IgA Fc receptor I (CD89) gene in a cosmid clone. Immunogenetics 49 586-589 ( 1999 (Pubitemid 29221799)
46. Tsuge T. Shimokawa T. Horikoshi S. Tomino Y. & Ra C. Polymorphism in promoter region of Fc alpha receptor gene in patients with IgA nephropathy. Hum. Genet. 108 128-133 ( 2001 (Pubitemid 32215372)
47. Jasek M. et al. A novel polymorphism in the cytoplasmic region of the human immunoglobulin A Fc receptor gene. Eur. J. Immunogenet. 31 59-62 ( 2004 (Pubitemid 38580922)
48. Kaneko S. et al. A novel polymorphism of Fc alphaRI (CD89) associated with aggressive periodontitis. Tissue Antigens 63 572-577 ( 2004 (Pubitemid 38748008)
49. Watanabe A. et al. Genetic variants of the IgA Fc receptor (Fc alphaRCD89) promoter in chronic hepatitis C patients. Immunogenetics 58 937-946 ( 2006 (Pubitemid 44791227)
50. Wu J. et al. Fc alphaRI (CD89) alleles determine the proinfl amatory potential of serum IgA. J. Immunol. 178 3973-3982 ( 2007 (Pubitemid 46417668)
51. Bournazos S. Woof J. M. Hart S. P. & Dransfi eld I. Functional and clinical consequences of Fc receptor polymorphic and copy number variants. Clin. Exp. Immunol. 157 244-254 ( 2009
52. Jasek M. et al. Are single nucleotide polymorphisms of the immunoglobulin A Fc receptor gene associated with allergic asthma? Int. Arch. Allergy Immunol. 135 325-331 ( 2004 (Pubitemid 40082198)
53. Broen J. C. et al. The functional polymorphism 844 A > G in Fc alphaRI (CD89) does not contribute to systemic sclerosis or rheumatoid arthritis susceptibility. J. Rheumatol. 38 446-449.
54. Narita I. et al. Genetic polymorphisms in the promoter and 5 UTR region of the Fc alpha receptor (CD89) are not associated with a risk of IgA nephropathy. J. Hum. Genet. 46 694-698 ( 2001 (Pubitemid 34037329)
55. Sibille Y. Chatelain B. Staquet P. Delacroix D. L. & Vaerman J. P. IgA receptors on human alveolar macrophages. Monogr. Allergy 24 282-286 ( 1988
56. van Egmond M. et al. Fc alphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity. Nat. Med. 6 680-685 ( 2000 (Pubitemid 30398792)
57. Geissmann F. et al. A subset of human dendritic cells expresses IgA Fc receptor (CD89)which mediates internalization and activation upon cross-linking by IgA complexes. J. Immunol. 166 346-352 ( 2001 (Pubitemid 32038451)
58. Smith P. D. et al. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J. Immunol. 167 2651-2656 ( 2001 (Pubitemid 32768894)
59. Heystek H. C. Moulon C. Woltman A. M. Garonne P. & van Kooten C. Human immature dendritic cells effi ciently bind and take up secretory IgA without the induction of maturation. J. Immunol. 168 102-107 ( 2002 (Pubitemid 34014108)
60. Qian K. et al. Functional expression of IgA receptor Fc alphaRI on human platelets. J. Leukoc. Biol. 84 1492-1500 ( 2008 (Pubitemid 352774484)
61. Chevailler A. Monteiro R. C. Kubagawa H. & Cooper M. D. Immunofl uorescence analysis of IgA binding by human mononuclear cells in blood and lymphoid tissue. J. Immunol. 142 2244-2249 ( 1989 (Pubitemid 19098231)
62. Bakema J. E. et al. c-Jun activating binding protein 1 binds to the IgA receptor and modulates protein levels of Fc alphaRI and FcR gammachain . Eur. J. Immunol. 40 2035-2040 ( 2010
63. Shen L. Collins J. E. Schoenborn M. A. & Maliszewski C. R. Lipopolysaccharide and cytokine augmentation of human monocyte IgA receptor expression and function. J. Immunol. 152 4080-4086 ( 1994 (Pubitemid 24111080)
64. Gessl A. et al. Infl uence of tumour necrosis factor-alpha on the expression of Fc IgG and IgA receptorsand other markers by cultured human blood monocytes and U937 cells. Scand. J. Immunol. 39 151-156 ( 1994 (Pubitemid 24253195)
65. Hostoffer R. W. Krukovets I. & Berger M. Increased Fc alpha R expression and IgA-mediated function on neutrophils induced by chemoattractants. J. Immunol. 150 4532-4540 ( 1993 (Pubitemid 23133730)
66. Hostoffer R. W. Krukovets I. & Berger M. Enhancement by tumor necrosis factor-alpha of Fc alpha receptor expression and IgA-mediated superoxide generation and killing of Pseudomonas aeruginosa by polymorphonuclear leukocytes. J. Infect. Dis. 170 82-87 ( 1994 (Pubitemid 24186428)
67. Reterink T. J. Levarht E. W. Klar-Mohamad N. Van Es L. A. & Daha M. R. Transforming growth factor-beta 1 (TGF-beta 1) down-regulates IgA Fc-receptor (CD89) expression on human monocytes. Clin. Exp. Immunol. 103 161-166 ( 1996 (Pubitemid 26029477)
68. Grossetete B. et al. Down-regulation of Fc alpha receptors on blood cells of IgA nephropathy patients: evidence for a negative regulatory role of serum IgA. Kidney Int. 53 1321-1335 ( 1998 (Pubitemid 28316894)
69. Hamre R. Farstad I. N. Brandtzaeg P. & Morton H. C. Expressionand modulation of the human immunoglobulin A Fc receptor (CD89) and the FcR gamma chain on myeloid cells in blood and tissue. Scand. J. Immunol. 57 506-516 ( 2003 (Pubitemid 36734990)
70. Grossetete B. Viard J. P. Lehuen A. Bach J. F. & Monteiro R. C. Impaired Fc alpha receptor expression is linked to increased immunoglobulin A levels and disease progression in HIV-1-infected patients. AIDS 9 229-234 ( 1995
71. Chiamolera M. et al. Enhanced expression of Fc alpha receptor I on blood phagocytes of patients with gram-negative bacteremia is associated with tyrosine phosphorylation of the FcR-gamma subunit. Shock 16 344-348 ( 2001 (Pubitemid 33598208)
72. Montenegro V. Chiamolera M. Launay P. Goncalves C. R. & Monteiro R. C. Impaired expression of IgA Fc receptors (CD89) by blood phagocytic cells in ankylosing spondylitis. J. Rheumatol. 27 411 - 417 ( 2000 (Pubitemid 30095474)
73. Wines B. D. et al. Identifi cation of residues in the fi rst domain of human Fc alpha receptor essential for interaction with IgA. J. Immunol. 162 2146-2153 ( 1999 (Pubitemid 29288836)
74. Wines B. D. Sardjono C. T. Trist H. H. Lay C. S. & Hogarth P. M. The interaction of Fc alpha RI with IgA and its implications for ligand binding by immunoreceptors of the leukocyte receptor cluster. J. Immunol. 166 1781-1789 ( 2001 (Pubitemid 32114663)
75. Herr A. B. Ballister E. R. & Bjorkman P. J. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc. Nature 423 614-620 ( 2003 (Pubitemid 36713216)
76. Ding Y. et al. Crystal structure of the ectodomain of human Fc alphaRI. J. Biol. Chem. 278 27966-27970 ( 2003 (Pubitemid 36899991)
77. Oortwijn B. D. et al. Monomeric and polymeric IgA show a similar association with the myeloid Fc alphaRI/CD89. Mol. Immunol. 44 966-973 ( 2007 (Pubitemid 44429976)
78. van Spriel A. B. et al. Mac-1 (CD11b/CD18) is essential for Fc receptormediated neutrophil cytotoxicity and immunologic synapse formation. Blood 97 2478-2486 ( 2001 (Pubitemid 32291496)
79. Woof J. M. & Burton D. R. Human antibody-Fc receptor interactions illuminated by crystal structures. Nat. Rev. Immunol. 4 89-99 ( 2004 (Pubitemid 38209203)
80. Bonner A. Almogren A. Furtado P. B. Kerr M. A. & Perkins S. J. Location of secretory component on the Fc edge of dimeric IgA1 reveals insight into the role of secretory IgA1 in mucosal immunity. Mucosal. Immunol. 2 74-84 ( 2009
81. Shi J. et al. Interaction of the low-affi nity receptor CD23/Fc epsilon RII lectin domain with the Fc epsilon3-4 fragment of human immunoglobulin E. Biochemistry 36 2112-2122 ( 1997 (Pubitemid 27104702)
82. Keown M. B. Ghirlando R. Mackay G. A. Sutton B. J. & Gould H. J. Basis of the 1:1 stoichiometry of the high affi nity receptor Fc epsilon RI-IgE complex. Eur. Biophys. J. 25 471-476 ( 1997 (Pubitemid 27305866)
83. Sondermann P. Huber R. Oosthuizen V. & Jacob U. The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. Nature 406 267-273 ( 2000 (Pubitemid 30604397)
84. Keown M. B. Henry A. J. Ghirlando R. Sutton B. J. & Gould H. J. Thermodynamics of the interaction of human immunoglobulin E with its high-affi nity receptor Fc epsilon RI. Biochemistry 37 8863-8869 ( 1998 (Pubitemid 28299654)
85. Zhang Y. et al. Crystal structure of the extracellular domain of a human Fc gamma RIII. Immunity 13 387-395 ( 2000
86. Pleass R. J. Dunlop J. I. Anderson C. M. & Woof J. M. Identifi cation of residues in the CH2/CH3 domain interface of IgA essential for interaction with the human Fc alpha receptor (Fc alphaR) CD89. J. Biol. Chem. 274 23508-23514 ( 1999
87. Reterink T. J. et al. Size-dependent effect of IgA on the IgA Fc receptor (CD89). Eur. J. Immunol. 27 2219-2224 ( 1997 (Pubitemid 27404303)
88. Xue J. Zhao Q. Zhu L. & Zhang W. Deglycosylation of Fc alphaR at N58 increases its binding to IgA. Glycobiology 20 905-915 ( 2010
89. Gomes M. M. et al. Analysis of IgA1 N-glycosylation and its contribution to Fc alphaRI binding. Biochemistry 47 11285-11299 ( 2008
90. Mattu T. S. et al. The glycosylation and structure of human serum IgA1Faband Fc regions and the role of N-glycosylation on Fc alpha receptor interactions. J. Biol. Chem. 273 2260-2272 ( 1998 (Pubitemid 28069279)
91. Shen L. Lasser R. & Fanger M. W. My 43a monoclonal antibody that reacts with human myeloid cells inhibits monocyte IgA binding and triggers function. J. Immunol. 143 4117-4122 ( 1989 (Pubitemid 20012603)
92. Morton H. C. et al. Immunoglobulin-binding sites of human Fc alphaRI (CD89) and bovine Fc gamma2R are located in their membrane-distal extracellular domains. J. Exp. Med. 189 1715-1722 ( 1999 (Pubitemid 29272688)
93. Lu J. et al. Recognition and functional activation of the human IgA receptor (Fc{alpha}RI) by C-reactive protein. Proc. Natl Acad. Sci. USA 108 4974-4979 ( 2011
94. Weisbart R. H. Kacena A. Schuh A. & Golde D. W. GM-CSF induces human neutrophil IgA-mediated phagocytosis by an IgA Fc receptor activation mechanism. Nature 332 647-648 ( 1988
95. Baldwin G. C. et al. Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodefi ciency syndrome patients. Proc. Natl Acad. Sci. USA 85 2763-2766 ( 1988
96. Bracke M. et al. Differential effects of the T helper cell type 2-derived cytokines IL-4 and IL-5 on ligand binding to IgG and IgA receptors expressed by human eosinophils. J. Immunol. 159 1459-1465 ( 1997 (Pubitemid 127484126)
97. Bracke M. Lammers J. W. Coffer P. J. & Koenderman L. Cytokineinduced inside-out activation of Fc alphaR (CD89) is mediated by a single serine residue (S263) in the intracellular domain of the receptor. Blood 97 3478-3483 ( 2001
98. Bakema J. E. et al. Inside-out regulation of Fc alpha RI (CD89) depends on PP2A. J. Immunol. 181 4080-4088 ( 2008
99. Ginsberg M. H. Partridge A. & Shattil S. J. Integrin regulation. Curr. Opin. Cell Biol. 17 509-516 ( 2005 (Pubitemid 41267165)
100. Smith A. D. Streilein R. D. & Hall R. P. III Neutrophil CD11bL-selectin and Fc IgA receptors in patients with dermatitis herpetiformis. Br. J. Dermatol. 147 1109-1117 ( 2002 (Pubitemid 36963016)
101. Pfefferkorn L. C. & Yeaman G. R. Association of IgA-Fc receptors (Fc alpha R) with Fc epsilon RI gamma 2 subunits in U937 cells. Aggregation induces the tyrosine phosphorylation of gamma 2. J. Immunol. 153 3228-3236 ( 1994
102. Morton H. C. et al. Functional association between the human myeloid immunoglobulin A Fc receptor (CD89) and FcR gamma chain. Molecular basis for CD89/FcR gamma chain association. J. Biol. Chem. 270 29781-29787 ( 1995
103. van Egmond M. et al. Human immunoglobulin A receptor (Fc alphaRICD89) function in transgenic mice requires both FcR gamma chain and CR3 (CD11b/CD18). Blood 93 4387-4394 ( 1999 (Pubitemid 29279282)
104. Bakema J. E. et al. Signaling through mutants of the IgA receptor CD89 and consequences for Fc receptor gamma-chain interaction. J. Immunol. 176 3603-3610 ( 2006 (Pubitemid 43364008)
105. Wines B. D. Trist H. M. Monteiro R. C. Van Kooten C. & Hogarth P. M. Fc receptor gamma chain residues at the interface of the cytoplasmic and transmembrane domains affect association with Fc alphaRIsurface expressionand function. J. Biol. Chem. 279 26339-26345 ( 2004 (Pubitemid 38798784)
106. Wines B. D. Trist H. M. Ramsland P. A. & Hogarth P. M. A common site of the Fc receptor gamma subunit interacts with the unrelated immunoreceptors Fc alphaRI and Fc epsilonRI. J. Biol. Chem. 281 17108-17113 ( 2006
107. Launay P. et al. Alternative endocytic pathway for immunoglobulin A Fc receptors (CD89) depends on the lack of FcRgamma association and protects against degradation of bound ligand. J. Biol. Chem. 274 7216-7225 ( 1999
108. Honorio-Franca A. C. Launayp P. Carneiro-Sampaio M. M. & Monteiro R. C. Colostral neutrophils express Fc alpha receptors (CD89) lacking gamma chain association and mediate noninfl ammatory properties of secretory IgA. J. Leukoc. Biol. 69 289-296 ( 2001 (Pubitemid 32163442)
109. Shen L. et al. Presentation of ovalbumin internalized via the immunoglobulin-A Fc receptor is enhanced through Fc receptor gamma-chain signaling. Blood 97 205-213 ( 2001 (Pubitemid 32061262)
110. Lanier L. L. Corliss B. C. Wu J. Leong C. & Phillips J. H. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391 703-707 ( 1998 (Pubitemid 28113218)
111. Westgaard I. H. et al. Rat NKp46 activates natural killer cell cytotoxicity and is associated with Fc epsilon RI gamma and CD3zeta. J. Leukoc. Biol. 76 1200-1206 ( 2004 (Pubitemid 39602956)
112. Kim M. K. et al. Fc gamma receptor transmembrane domains: role in cell surface expressiongamma chain interactionand phagocytosis. Blood 101 4479-4484 ( 2003
113. Ravetch J. V. & Kinet J. P. Fc receptors. Annu. Rev. Immunol. 9 457-492 ( 1991
114. Kinet J. P. The high-affi nity receptor for IgE. Curr. Opin. Immunol. 2 499-505 ( 1989
115. Lang M. L. Shen L. & Wade W. F. Gamma-chain dependent recruitment of tyrosine kinases to membrane rafts by the human IgA receptor Fc alpha R. J. Immunol. 163 5391-5398 ( 1999
116. Gulle H. Samstag A. Eibl M. M. & Wolf H. M. Physical and functional association of Fc alpha R with protein tyrosine kinase Lyn. Blood 91 383-391 ( 1998 (Pubitemid 28053359)
117. Launay P. Lehuen A. Kawakami T. Blank U. & Monteiro R. C. IgA Fc receptor (CD89) activation enables coupling to syk and Btk tyrosine kinase pathways: differential signaling after IFN-gamma or phorbol ester stimulation. J. Leukoc. Biol. 63 636-642 ( 1998 (Pubitemid 28193778)
118. Shen L. Lang M. L. & Wade W. F. The ins and outs of getting in: structures and signals that enhance BCR or Fc receptor-mediated antigen presentation. Immunopharmacology 49 227-240 ( 2000
119. Lang M. L. et al. Fc alpha receptor cross-linking causes translocation of phosphatidylinositol-dependent protein kinase 1 and protein kinase B alpha to MHC class II peptide-loading-like compartments. J. Immunol. 166 5585-5593 ( 2001 (Pubitemid 32374181)
120. Chen Y. W. Lang M. L. & Wade W. F. Protein kinase C-alpha and -delta are required for Fc alphaR (CD89) traffi cking to MHC class II compartments and Fc alphaR-mediated antigen presentation. Traffi c 5 577-594 ( 2004 (Pubitemid 39144488)
121. Park R. K. Izadi K. D. Deo Y. M. & Durden D. L. Role of Src in the modulation of multiple adaptor proteins in Fc alphaRI oxidant signaling. Blood 94 2112-2120 ( 1999 (Pubitemid 29430428)
122. Lang M. L. & Kerr M. A. Characterization of Fc alphaR-triggered Ca(2+) signals: role in neutrophil NADPH oxidase activation. Biochem. Biophys. Res. Commun. 276 749-755 ( 2000
123. Vidarsson G. et al. Activity of human IgG and IgA subclasses in immune defense against Neisseria meningitidis serogroup B. J. Immunol. 166 6250-6256 ( 2001 (Pubitemid 32440757)
124. Hellwig S. M. van Spriel A. B. Schellekens J. F. Mooi F. R. & van de Winkel J. G. Immunoglobulin A-mediated protection against Bordetella pertussis infection. Infect. Immun. 69 4846-4850 ( 2001 (Pubitemid 32674464)
125. Ouadrhiri Y. Pilette C. Monteiro R. C. Vaerman J. P. & Sibille Y. Effect of IgA on respiratory burst and cytokine release by human alveolar macrophages: role of ERK1/2 mitogen-activated protein kinases and NF-kappaB. Am. J. Respir. Cell Mol. Biol. 26 315-332 ( 2002 (Pubitemid 34170058)
126. Pilette C. Detry B. Guisset A. Gabriels J. & Sibille Y. Induction of interleukin-10 expression through Fc alpha receptor in human monocytes and monocyte-derived dendritic cells: role of p38 MAPKinase. Immunol. Cell Biol. 88 486-493.
127. Otten M. A. et al. Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors. J. Immunol. 174 5472-5480 ( 2005 (Pubitemid 40593187)
128. Otten M. A. et al. FcR gamma-chain dependent signaling in immature neutrophils is mediated by Fc alphaRIbut not by Fc gammaRI. J. Immunol. 179 2918-2924 ( 2007
129. Pleass R. J. Lang M. L. Kerr M. A. & Woof J. M. IgA is a more potent inducer of NADPH oxidase activation and degranulation in blood eosinophils than IgE. Mol. Immunol. 44 1401-1408 ( 2007 (Pubitemid 44415953)
130. van der Steen L. et al. Immunoglobulin A: Fc(alpha)RI interactions induce neutrophil migration through release of leukotriene B4. Gastroenterology 137 2018 - 2029 e2011 - 2013 ( 2009
131. Pasquier B. et al. Identifi cation of Fc alphaRI as an inhibitory receptor that controls infl ammation: dual role of FcR gamma ITAM. Immunity 22 31-42 ( 2005 (Pubitemid 40143449)
132. Kanamaru Y. Blank U. & Monteiro R. C. IgA Fc receptor I is a molecular switch that determines IgA activating or inhibitory functions. Contrib. Nephrol. 157 148-152 ( 2007
133. Van Epps D. E. & Brown S. L. Inhibition of formylmethionyl- leucylphenylalanine- stimulated neutrophil chemiluminescence by human immunoglobulin A paraproteins. Infect. Immun. 34 864-870 ( 1981 (Pubitemid 12247186)
134. Van Epps D. E. & Williams R. C. Jr. Suppression of leukocyte chemotaxis by human IgA myeloma components. J. Exp. Med. 144 1227-1242 ( 1976
135. Van Epps D. E. Reed K. & Williams R. C. Jr. Suppression ofhuman PMN bactericidal activity by human IgA paraproteins. Cell Immunol. 36 363-376 ( 1978 (Pubitemid 8315518)
136. Wilton J. M. Suppression by IgA of IgG-mediated phagocytosis by human polymorphonuclear leucocytes. Clin. Exp. Immunol. 34 423-428 ( 1978 (Pubitemid 9092589)
137. Wolf H. M. et al. Human serum IgA downregulates the release of infl ammatory cytokines (tumor necrosis factor-alphainterleukin-6) in human monocytes. Blood 83 1278-1288 ( 1994 (Pubitemid 24062851)
138. Wolf H. M. & Eibl M. M. The anti-infl ammatory effect of an oral immunoglobulin (IgA-IgG) preparation and its possible relevance for the prevention of necrotizing enterocolitis. Acta. Paediatr. Suppl. 396 37-40 ( 1994 (Pubitemid 24186058)
139. Nikolova E. B. & Russell M. W. Dual function of human IgA antibodies: inhibition of phagocytosis in circulating neutrophils and enhancement of responses in IL-8-stimulated cells. J. Leukoc. Biol. 57 875-882 ( 1995
140. Pfi rsch-Maisonnas S. et al. Inhibitory ITAM signaling traps activating receptors with the phosphatase SHP-1 to form polarized " inhibisome " clusters. Sci. Signal. 4 ra24 ( 2011
141. Blank U. Launay P. Benhamou M. & Monteiro R. C. Inhibitory ITAMs as novel regulators of immunity. Immunol. Rev. 232 59-71 ( 2009
142. Pasquier B. Lepelletier Y. Baude C. Hermine O. & Monteiro R. C. Differential expression and function of IgA receptors (CD89 and CD71) during maturation of dendritic cells. J. Leukoc. Biol. 76 1134-1141 ( 2004 (Pubitemid 39602949)
143. Fayette J. et al. Human dendritic cells skew isotype switching of CD40- activated naive B cells towards IgA1 and IgA2. J. Exp. Med. 185 1909-1918 (1997) (Pubitemid 27247077)
144. Otten M. A. Groenveld I. van de Winkel J. G. & van Egmond M. Ineffi cient antigen presentation via the IgA Fc receptor (Fc alphaRI) on dendritic cells. Immunobiology 211 503-510 ( 2006
145. Mazanec M. B. Kaetzel C. S. Lamm M. E. Fletcher D. & Nedrud J. G. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc. Natl Acad. Sci. USA 89 6901-6905 ( 1992
146. Mazanec M. B. Coudret C. L. & Fletcher D. R. Intracellular neutralization of infl uenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J. Virol. 69 1339-1343 ( 1995
147. Mazanec M. B. et al. Intracellular neutralization of Sendai and infl uenza viruses by IgA monoclonal antibodies. Adv. Exp. Med. Biol. 371A 651-654 ( 1995
148. Devito C. et al. Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. J. Immunol. 165 5170-5176 ( 2000
149. Corthesy B. et al. Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion. J. Virol. 80 10692-10699 ( 2006 (Pubitemid 44628915)
150. Stubbe H. Berdoz J. Kraehenbuhl J. P. & Corthesy B. Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium diffi cile toxin A damaging of T84 monolayers. J. Immunol. 164 1952-1960 ( 2000 (Pubitemid 30108750)
151. Burns J. W. Siadat-Pajouh M. Krishnaney A. A. & Greenberg H. B. Protective effect of rotavirus VP6-specifi c IgA monoclonal antibodies that lack neutralizing activity. Science 272 104-107 ( 1996 (Pubitemid 26110760)
152. van Egmond M. Hanneke van Vuuren A. J. & van de Winkel J. G. The human Fc receptor for IgA (Fc alpha RICD89) on transgenic peritoneal macrophages triggers phagocytosis and tumor cell lysis. Immunol. Lett. 68 83-87 ( 1999 (Pubitemid 29265656)
153. Balu S. et al. A novel human IgA monoclonal antibody protects against tuberculosis. J. Immunol. 186 3113-3119 ( 2011
154. van Spriel A. B. et al. Effective phagocytosis and killing of Candida albicans via targeting Fc gammaRI (CD64) or Fc alphaRI (CD89) on neutrophils. J. Infect. Dis. 179 661-669 ( 1999 (Pubitemid 30016150)
155. van der Pol W. Vidarsson G. Vile H. A. van de Winkel J. G. & Rodriguez M. E. Pneumococcal capsular polysaccharide-specifi c IgA triggers effi cient neutrophil effector functions via Fc alphaRI (CD89). J. Infect. Dis. 182 1139-1145 ( 2000
156. Kobayashi T. et al. Effective in vitro clearance of Porphyromonas gingivalis by Fc alpha receptor I (CD89) on gingival crevicular neutrophils. Infect. Immun. 69 2935-2942 ( 2001 (Pubitemid 32332185)
157. Launay P. et al. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Bergers disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice. J. Exp. Med. 191 1999-2009 ( 2000 (Pubitemid 30390361)
158. Duchez S. et al. Premature replacement of mu with alpha immunoglobulin chains impairs lymphopoiesis and mucosal homing but promotes plasma cell maturation. Proc. Natl Acad. Sci. USA 107 3064-3069 ( 2010
159. Leibl H. Tomasits R. & Mannhalter J. W. Isolation of human serum IgA using thiophilic adsorption chromatography. Protein Expr. Purif. 6 408-410 ( 1995
160. Sandin C. et al. Isolation and detection of human IgA using a streptococcal IgA-binding peptide. J. Immunol. 169 1357-1364 ( 2002 (Pubitemid 34809179)
161. Beyer T. et al. Serum-free production and purifi cation of chimeric IgA antibodies. J. Immunol. Methods 346 26-37 ( 2009
162. Kanamaru Y. et al. Inhibitory ITAM signaling by Fc alpha RI-FcR gamma chain controls multiple activating responses and prevents renal infl ammation. J. Immunol. 180 2669-2678 ( 2008
163. Kanamaru Y. et al. IgA Fc receptor I signals apoptosis through the FcR gamma ITAM and affects tumor growth. Blood 109 203-211 ( 2007 (Pubitemid 46070122)
164. Monteiro R. C. The role of IgA and IgA Fc receptors as anti-infl amatory agents. J. Clin. Immunol. 30 (Suppl 1) S61 - 64 ( 2010
165. Blanchard T. G. et al. Urease-specifi c monoclonal antibodies prevent Helicobacter felis infection in mice. Infect. Immun. 63 1394-1399 ( 1995
166. Goto T. et al. Local secretory immunoglobulin A and postimmunization gastritis correlate with protection against Helicobacter pylori infection after oral vaccination of mice. Infect. Immun. 67 2531-2539 ( 1999 (Pubitemid 29200515)
167. Renegar K. B. & Small P. A. Jr. Passive transfer of local immunity to infl uenza virus infection by IgA antibody. J. Immunol. 146 1972-1978 ( 1991
168. Takase H. Murakami Y. Endo A. & Ikeuchi T. Antibody responses and protection in mice immunized orally against infl uenza virus. Vaccine 14 1651-1656 ( 1996 (Pubitemid 27041918)
169. Phalipon A. et al. Monoclonal immunoglobulin A antibody directed against serotype-specifi c epitope of Shigella fl exneri lipopolysaccharide protects against murine experimental shigellosis. J. Exp. Med. 182 769-778 ( 1995
170. Bomsel M. et al. Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges. Immunity 34 269-280 ( 2011
171. Duval M. Posner M. R. & Cavacini L. A. A bispecifi c antibody composed of a nonneutralizing antibody to the gp41 immunodominant region and an anti-CD89 antibody directs broad human immunodefi ciency virus destruction by neutrophils. J. Virol. 82 4671-4674 ( 2008 (Pubitemid 351563705)
172. Valerius T. et al. Fc alphaRI (CD89) as a novel trigger molecule for bispecifi c antibody therapy. Blood 90 4485-4492 ( 1997 (Pubitemid 27508454)
173. Deo Y. M. Sundarapandiyan K. Keler T. Wallace P. K. & Graziano R. F. Bispecifi c molecules directed to the Fc receptor for IgA (Fc alpha RICD89) and tumor antigens effi ciently promote cell-mediated cytotoxicity of tumor targets in whole blood. J. Immunol. 160 1677-1686 ( 1998 (Pubitemid 28106452)
174. Valerius T. et al. Activated neutrophils as effector cells for bispecifi c antibodies. Cancer Immunol. Immunother. 45 142-145 ( 1997 (Pubitemid 27521444)
175. Ma J. K. et al. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat. Med. 4 601-606 ( 1998 (Pubitemid 28237360)
176. Huls G. et al. Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodies. Cancer Res. 59 5778-5784 ( 1999
177. Stockmeyer B. et al. Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy. J. Immunol. 165 5954-5961 ( 2000
178. Dechant M. & Valerius T. IgA antibodies for cancer therapy. Crit. Rev. Oncol. Hematol. 39 69-77 ( 2001 (Pubitemid 32564867)
179. Stockmeyer B. et al. Mechanisms of G-CSF- or GM-CSF-stimulated tumor cell killing by Fc receptor-directed bispecifi c antibodies. J. Immunol. Methods 248 103-111 ( 2001 (Pubitemid 32167028)
180. Sundarapandiyan K. et al. Bispecifi c antibody-mediated destruction of Hodgkin's lymphoma cells. J. Immunol. Methods 248 113-123 ( 2001 (Pubitemid 32167029)
181. van Egmond M. et al. Enhancement of polymorphonuclear cellmediated tumor cell killing on simultaneous engagement of Fc gammaRI (CD64) and Fc alphaRI (CD89). Cancer Res. 61 4055-4060 ( 2001 (Pubitemid 32720970)
182. Dechant M. et al. Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing. Blood 100 4574-4580 ( 2002 (Pubitemid 35429700)
183. Dechant M. et al. Effector mechanisms of recombinant IgA antibodies against epidermal growth factor receptor. J. Immunol. 179 2936-2943 ( 2007
184. Zhao J. et al. Recombinant human monoclonal igA antibody against CEA to recruit neutrophils to CEA-expressing cells. Oncol Res. 17 217-222 ( 2008
185. Guettinger Y. et al. A recombinant bispecifi c single-chain fragment variable specifi c for HLA class II and Fc alpha RI (CD89) recruits polymorphonuclear neutrophils for effi cient lysis of malignant B lymphoid cells. J. Immunol. 184 1210-1217 ( 2010
186. Lohse S. et al. Recombinant dimeric IgA antibodies against the epidermal growth factor receptor mediate effective tumor cell killing. J. Immunol. 186 3770-3778 ( 2011
187. Bakema J. E. & van Egmond M. Immunoglobulin A: a next generation of therapeutic antibodies? mAbs. 3 352-361 ( 2011
188. Bakema J. E. et al. Targeting the immunoglobulin A Fc receptor (Fc alphaRI) on polymorphonuclear cells induces tumor cell killing through autophagy. J. Immunol. 187 726-732 ( 2011
189. Martin-Orozco N. et al. T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 31 787-798 ( 2009
190. Pelletier M. et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 115 335-343 ( 2010
191. Scapini P. et al. The neutrophil as a cellular source of chemokines. Immunol. Rev. 177 195-203 ( 2000